Hikma, the London-listed generic
drugmaker, has sharply increased the price of a string of medicines in the US — including
a diarrhoea treatment that has risen 430 per cent — in the latest instance of
您已閱讀9%（198字），剩余91%（2059字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。